Research on the High-Quality Development of the Distinctive Health and Pharmaceutical Industry

ZhiYi Tang

doi:10.63313/EBM.9146

Authors

ZhiYi Tang Southwest Petroleum University of Economics and Management, Chengdu, 610500, China Author

DOI:

https://doi.org/10.63313/EBM.9146

Keywords:

Distinctive health and pharmaceutical industry, high-quality development, literature review, evaluation indicator system, Sichuan Province

Abstract

Under the background of the new development philosophy and the Healthy China strategy, the distinctive health and pharmaceutical industry has become an important carrier for promoting regional industrial transformation and improving public health supply. Existing studies have explored the connotation, driving mechanisms, and evaluation measurement of high-quality development in areas such as the traditional Chinese medicine (TCM) health industry, biopharma-ceuticals, and ethnic medicine. However, shortcomings remain in terms of conceptual boundaries, mechanism explanations, and the adaptation to provincial contexts. This paper systematically reviews related domestic and international literature. From management perspectives such as the resource-based view and dynamic capabilities, industrial ecosystems and value-chain co-ordination, and institutional environment and policy instruments, it summarizes key findings on the high-quality development of the distinctive health and pharmaceutical industry and compar-atively discusses evaluation dimensions and comprehensive evaluation methods. On this basis, considering Sichuan’s resource endowments and industrial characteristics, the paper clarifies the connotation of high-quality development of the distinctive health and pharmaceutical industry and constructs an evaluation framework covering industrial development foundation, development momentum, development efficiency, and development environment, providing theoretical foundations and tool support for policy optimization and management practice in Sichuan’s distinctive health and pharmaceutical industry.

References

[1] Ma Jifei, Zhang Wenlong. Research on the high-quality development of the traditional Chinese medicine (TCM) health industry in the Guangdong–Hong Kong–Macao Greater Bay Area [J]. Health Economics Research, 2023, 40(04): 24–27, 33.

[2] Jiang Weiyan, Zhang Delin. Analysis of the connotation of high-quality development of the TCM industry and path selection [J]. Journal of Jiangxi University of Chinese Medicine, 2023, 35(06): 109–112.

[3] Zhang Pengfei. An exploration of the evaluation system and development paths for high-quality development of the TCM industry [J]. Industrial Innovation Research, 2025(01): 104–106.

[4] Zhang Mingjing, Zhang Mingjiu. Discussion on the evaluation indicator system for high-quality development of the TCM industry [J]. Industry and Technology Forum, 2021, 20(05): 12–15.

[5] Wei Min, Li Shuhao. Measurement of China’s high-quality economic development level in the new era [J]. The Journal of Quantitative & Technical Economics, 2018, 35(11): 3–20.

[6] Ren Baoping, Li Yumo. Constructing an evaluation system for high-quality development in China’s new era and its transformation path [J]. Journal of Shaanxi Normal University (Philosophy and Social Sciences Edition), 2018, 47(03): 105–113.

[7] Li Jinchang, Shi Longmei, Xu Aiting. Discussion on the evaluation indicator system for high-quality development [J]. Statistical Research, 2019, 36(01): 4–14.

[8] Wei Tao. Construction and empirical study of an evaluation indicator system for China’s provincial health industry [J]. Statistics & Decision, 2024, 40(12): 87–91.

[9] Liu Mingyuan. Construction and empirical research on an evaluation indicator system for high-quality industrial development in China [J]. Journal of Shijiazhuang University, 2021, 23(04): 55–62.

[10] Chen Jiaxi, Liu Qinmin. Paths to improve the high-quality development of the TCM cultural industry in the Guangdong–Hong Kong–Macao Greater Bay Area [J]. Soft Science of Health, 2025, 39(10): 1–6.

[11] Chen Jingjing, Zhang Chao. Performance evaluation of high-quality development in the biopharmaceutical industry [J]. Business Observation, 2025, 11(28): 16–19.

[12] Li Yan. Measuring the level of high-quality development of the Chinese medicinal materials industry in Sichuan Province [J]. Commercial Economy, 2025(07): 74–77, 179.

[13] Tan Qingli, Zhu Jinjing, Huang Ziran. Assessment and countermeasures for the high-quality development of Guangdong’s biopharmaceutical industry [J]. China Science & Technology Resources Review, 2025, 57(02): 94–104.

[14] Li Guigui, Li Meng, Wang Ying, et al. A 10-year retrospective analysis of China’s pharmaceutical industry and development suggestions [J]. China Pharmaceuticals, 2024, 33(24): 1–11.

[15] Jin Bei. Economic research on “high-quality development” [J]. China Industrial Economics, 2018(04): 5–18.

[16] Jiang Wenwen, He Chao. Evaluation of mechanisms for realizing the value of ecological products under the background of high-quality development [J]. Journal of Beijing Forestry University (Social Sciences), 2025(05): 1–10.

[17] Li Xingchen, Fan Taotao, Chen Xiangru, et al. High-quality development of the TCM health industry driven by new-quality productive forces [J]. Soft Science of Health, 2025, 39(07): 17–23.

[18] Sun Qi, Li Yong. New-quality productive forces empowering high-quality development of the pharmaceutical industry: theoretical logic and practical paths [J]. Chinese Journal of New Drugs, 2025, 34(05): 465–472.

[19] Huang Juan. Reflections on high-quality development of the health industry in the context of Chinese modernization [J]. Enterprise Economy, 2024, 43(12): 5–13, 2.

[20] Liu Yaqin, Zhang Mengxiao, Chu Zhan, et al. Optimizing the innovation policy environment to support high-quality development of the pharmaceutical industry: an analysis and reflections on China’s drug R&D innovation trends [J]. Price: Theory & Practice, 2024(05): 82–86, 222.

[21] Liu Shaohuan, Luo Qinyu, Liang Yuyan, et al. Current development status and reflections on the Miao medicine industry in Sichuan [J]. Chinese Medicinal Materials, 2023, 46(04): 801–805.

[22] Jiang Cheng, Li Shunxiang. Reflections on the high-quality development of the TCM industry [J]. People’s Tribune, 2021(03): 92–93.

[23] Feng Si. Research on high-quality development of traditional Chinese medicine industry [J]. Economic Problems, 2022(06): 94–102.

[24] Chen Yingjie, Yang Ye. Theoretical logic and realization paths of new-quality productive forces enabling high-quality development of the TCM industry [J]. Modern Management Science, 2025(03): 90–97.

[25] Chen Ning, Dong Yanting. Research on constructing an indicator system for high-quality development of the “big health” industry in Liaoning [J]. Soft Science of Health, 2023, 37(04): 20–23.

[26] Chen Leilan. Evaluation indicator system and measurement of high-quality industrial development in China [J]. Science and Technology Innovation and Productivity, 2023(02): 40–43, 47.

[27] Gao Chongmin, Huang Jie, Xu Zhongyu, et al. Construction of an evaluation indicator system for high-quality development of rural characteristic industries in Guangxi [J]. Journal of Southern Agriculture, 2022, 53(08): 2373–2382.

[28] Hai Qingshan, Jin Yaju. The connotation and basic characteristics of the “big health” concept [J]. Journal of Traditional Chinese Medicine, 2017, 58(13): 1085–1088.

[29] Liu Jing, Zhao Yang, Sun Ying, et al. Exploration of constructing an evaluation indicator system for regional TCM health service capacity [J]. Chinese Health Economics, 2025, 44(10): 75–79.

[30] Zhang Lin, Ren Hongli, Liu Hongning. Connotation, evaluation system, and basic paths for high-quality development of the TCM industry [J]. New Chinese Medicine, 2024, 56(15): 181–188.

[31] Ma Feicheng, Li Gang. Information Resource Management [M]. Wuhan: Wuhan University Press, 2001.

[32] Fan Shanshan. An analysis of Weinberg’s view of natural laws based on systems science theory [J]. Journal of Systems Science, 2023, 31(3): 89–93.